LAS VEGAS, Dec. 27, 2011 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, is pleased to announce it has signed an exclusive agreement to store stem cells at its Las Vegas laboratory for the National Children's Leukemia Foundation (NCLF), New York.
"The National Children's Leukemia Foundation has a track record of success in individual counseling and medical referrals for thousands of patients, providing them financial assistance for housing, food and transportation, supporting scientists working on cutting-edge research, and arranging flights, medical care and hospitality for international patients in need of medical care in the U.S," said Matthew Schissler, Cord Blood America CEO and co-founder. "We are pleased to be chosen by the NCLF for its storage needs."
"Many lives have been saved, many wishes have been granted and many patients have benefited from our referrals and advocacy efforts in the two decades since our establishment," said Yehuda Gutwein, NCLF President. "We also are pleased to sign this exclusive agreement because we are aware of both the quality of the personnel and the care taken in storage by Cord Blood America."
"It's an honor to move our relationship from speaking about the benefits for children with leukemia, to storing stem cells for these same children," said Lea Ann Stiller, representative of Cord Blood America and featured speaker for National Children's Leukemia Foundation.
About Cord Blood America
Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/. To find out more information about the National Children's Leukemia Foundation, please visit their website at www.leukemiafoundation.org.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
SOURCE Cord Blood America, Inc.
